Caged xanthones: Potent inhibitors of global predominant MRSA USA300

Caged xanthones: Potent inhibitors of global predominant MRSA USA300 Modified tetra-oxygenated xanthones analogues as anti-MRSA and P. aeruginosa agent and their synergism with vancomycin Nonpeptidic Amphiphilic Xanthone Derivatives: Structure–Activity Relationship and Membrane-Targeting Properties Amino Acid Modified Xanthone Derivatives: Novel, Highly Promising Membrane-Active Antimicrobials for Multidrug-Resistant Gram-Positive Bacterial Infections Antibacterial Activity of Xanthones from Guttiferaeous Plants against Methicillin-resistant <i>Staphylococcus aureus</i> Antistaphylococcal Prenylated Acylphoroglucinol and Xanthones from <i>Kielmeyera variabilis</i> Design and Synthesis of Amphiphilic Xanthone-Based, Membrane-Targeting Antimicrobials with Improved Membrane Selectivity Citreamicins with Potent Gram-Positive Activity Citreamicins with Potent Gram-Positive Activity Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity